MicroRNA Childhood Cancer Catalog (M3Cs)

Publication Title	DOI	Year
Differential microRNA expression in childhood B-cell precursor acute lymphoblastic leukemia	https://doi.org/10.1080/08880010802378338	2009	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 5 Master/Detail View
High level of miR-196b at newly diagnosed pediatric acute myeloid leukemia predicts a poor outcome	https://doi.org/10.17179/excli2016-707	2017	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 3 Master/Detail View
Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation	https://doi.org/10.1186/s12885-015-1661-7	2015	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 4 Master/Detail View
Comprehensive Investigation of miRNome Identifies Novel Candidate miRNA-mRNA Interactions Implicated in T-Cell Acute Lymphoblastic Leukemia.	https://doi.org/10.1016/j.neo.2019.01.004	2019	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 13 Master/Detail View
Comprehensive miRNA expression profiling in human T-cell acute lymphoblastic leukemia by small RNA-sequencing.	https://doi.org/10.1038/s41598-017-08148-x	2017	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 10 Master/Detail View
MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemia	https://doi.org/10.18632/oncotarget.10270	2016	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 3 Master/Detail View
Onco-microRNA miR-130b promoting cell growth in children APL by targeting PTEN	https://doi.org/10.1016/j.apjtm.2016.01.024	2016	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
MicroRNA expression profiles discriminate childhood T- from B-acute lymphoblastic leukemia.	https://doi.org/10.1002/hon.2567	2019	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 16 Master/Detail View
Expression of certain leukemia/lymphoma related microRNAs and its correlation with prognosis in childhood acute lymphoblastic leukemia.	https://doi.org/10.1007/s12253-014-9861-z	2014	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 2 Master/Detail View
Differential MiRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features	https://doi.org/10.1016/j.leukres.2011.10.005	2012	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 5 Master/Detail View
Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53.	https://doi.org/10.1038/leu.2009.208	2010	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 3 Master/Detail View
Expression of miR-196b is not exclusively MLL-driven but is especially linked to activation of HOXA genes in pediatric acute lymphoblastic leukemia.	https://doi.org/10.3324/haematol.2010.023481	2010	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
High expression of miR-125b-2 and SNORD116 noncoding RNA clusters characterize ERG-related B cell precursor acute lymphoblastic leukemia.	https://doi.org/10.18632/oncotarget.16392	2017	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
MicroRNA characterize genetic diversity and drug resistance in pediatric acute lymphoblastic leukemia	https://doi.org/10.3324/haematol.2010.026138	2011	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 19 Master/Detail View
miR-187-5p Regulates Cell Growth and Apoptosis in Acute Lymphoblastic Leukemia via DKK2.	https://doi.org/10.3727/096504016X14597766487753	2016	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
MiR-708-5p is differentially expressed in childhood acute lymphoblastic leukemia but not strongly associated to clinical features	https://doi.org/10.1002/pbc.25222	2015	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
miRNA-155 and miRNA-181a as prognostic biomarkers for pediatric acute lymphoblastic leukemia.	https://doi.org/10.1002/jcb.27918	2018	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 2 Master/Detail View
Selected miRNA levels are associated with IKZF1 microdeletions in pediatric acute lymphoblastic leukemia.	https://doi.org/10.3892/ol.2017.6599	2017	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 12 Master/Detail View
In vitro knock-out of miR-155 suppresses leukemic and HCV virus loads in pediatric HCV-4-associated acute lymphoid leukemia: A promising target therapy.	https://doi.org/10.1002/jcb.29512	2019	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View
Upregulation of microRNA-21 is a poor prognostic marker in patients with childhood B cell acute lymphoblastic leukemia.	https://doi.org/10.1080/10245332.2017.1292204	2017	Cell line 0 Master/Detail View	Cell line and drug 0 Master/Detail View	Clinical and drug 0 Master/Detail View	Clinical 1 Master/Detail View

Publications